/
/
/

Marksans Pharma Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)314.20
Volume (₹)2.25 L
High (₹)315.10
Upper Circuit376.95
Low (₹)309.85
Lower Circuit251.35
Prev Close314.15
52W High (₹)350.95
Price313.20
52W Low (₹)155.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)14236.10 Cr
Div. Yield (%)0.29
PE Ratio27.55
Debt to Equity0.01
Price to Book2.36
Book Value66.64
EPS (TTM)11.40
Face Value1.00
ROE (%)15.31

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
MARKSANSNSE
LTP
1W Low
1W High
Market cap (₹)
1758.1-1.9 (-0.11%)
1725.50
1776.60
4,19,620Cr
9052.5-287.5 (-3.08%)
8937.50
9431.50
2,39,714Cr
4636.7-20.2 (-0.43%)
4551.80
4682
1,74,741Cr
1132+14.5 (1.30%)
1107.30
1150.90
1,12,119Cr
2038.4+1.8 (0.09%)
2007.80
2069.20
1,10,008Cr
1329.8+28.8 (2.21%)
1300.20
1333.30
1,06,061Cr
1228.4+31.4 (2.62%)
1196.90
1250.70
1,01,339Cr
2352.5-16 (-0.68%)
2317.50
2426.80
96,244Cr
1675.4-17.6 (-1.04%)
1647.10
1715
95,590Cr
1977.6+21.1 (1.08%)
1925.70
1979.90
89,391Cr
313.2+4.1 (1.33%)
309
320.90
14,236Cr

Key Highlights of Marksans Pharma Ltd Balance Sheet

Marksans Pharma Ltd balance sheet discloses shareholders' funds of ₹45.32Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹45.32Cr, and the reserves and surplus of the company is ₹1603.66Cr.

The company has its non-current liabilities with total liabilities of ₹2055.64Cr as of 2026-03-31.

The current liabilities are ₹371.86Cr as of 2026-03-31. At the same time, current assets are ₹1370.68Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹267.21Cr and tangible assets of ₹397.96Cr, provided in the Marksans Pharma Ltd financial statements.